SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Scien - Quaterly Results

01 Nov 2025 Evaluate
The total revenue for the quarter ended September 2025 remained nearly unchanged at Rs. 5221.52 millions.Net profit for the quarter ended September 2025 increased significantly by 85.67% to Rs. 320.40 millions from Rs. 172.56 millions.The Operating Profit of the company witnessed a decrease to 763.15 millions from 789.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 5221.52 5195.48 0.50 10207.68 10325.48 -1.14 21394.23 18661.17 14.65
Other Income 140.92 235.47 -40.15 158.50 316.38 -49.90 461.88 587.11 -21.33
PBIDT 763.15 789.12 -3.29 1453.04 1520.51 -4.44 3086.30 2092.16 47.52
Interest 294.13 418.25 -29.68 598.61 823.38 -27.30 1459.12 1393.77 4.69
PBDT 469.02 370.77 26.50 854.43 697.03 22.58 1626.91 644.74 152.34
Depreciation 215.14 206.97 3.95 436.52 413.19 5.65 846.08 874.07 -3.20
PBT 253.88 163.80 54.99 417.91 283.84 47.23 780.83 -229.33 -440.48
TAX -66.52 -8.76 659.36 -35.96 2.94 -1323.13 189.27 13.42 1310.36
Deferred Tax 47.17 21.46 119.80 78.20 22.57 246.48 203.91 14.61 1295.69
PAT 320.40 172.56 85.67 453.87 280.90 61.58 591.56 -242.75 -343.69
Equity 921.73 919.58 0.23 921.73 919.58 0.23 921.63 919.00 0.29
PBIDTM(%) 14.62 15.19 -3.77 14.23 14.73 -3.33 14.43 11.21 28.67

Strides Pharma Scien Share Price

1155.85 11.30 (0.99%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×